Mirataz Transdermal Ointment (5 g)

Product Description

Mirataz (mirtazapine transdermal ointment) is a white to off-white ointment containing 2% (w/w) of mirtazapine suitable for transdermal (topical) administration. Mirataz contains the following inactive ingredients: Polyethylene Glycol (PEG) 400, PEG 3350, Diethylene Glycol Monoethyl Ether, PEG-8 Caprylic/Capric Glycerides, Oleyl Alcohol, Butylated Hydroxytoluene, Dimethicone, and Dry Flo TS. Mirataz (mirtazapine transdermal ointment) is indicated for the management of weight loss in cats.

Possible Side Effects

The most common adverse reactions included application site reactions, behavioral abnormalities (vocalization and hyperactivity), and vomiting.

Recommended Dosage

Use as directed by your veterinarian. 1.5 inch ribbon (~2mg/cat) for 14 days

Storage Instructions

Store below 77 F.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.